Critical Matters Management of pneumonia in the ICU
19 snips
Jun 26, 2025 Dr. Andre Kalil, a critical care physician and expert in infectious diseases, shares vital insights on managing pneumonia in critically ill patients. He emphasizes the importance of updated definitions for pneumonia types and the way these affect treatment strategies. Kalil discusses the role of tracheal aspirates over bronchoscopy in diagnosing ventilator-associated pneumonia. He highlights the significance of local antibiograms to tailor antibiotic choices and suggests cautious use of corticosteroids in severe cases. His practical tips can greatly enhance outcomes in the ICU.
AI Snips
Chapters
Transcript
Episode notes
Three Factors Should Drive VAP Empiric Choice
- Choose empiric VAP coverage based on three factors: epidemiology, local antibiogram, and clinical severity.
- Escalate coverage when prior antibiotics, long hospitalization, septic shock, ARDS, or AKI are present.
Reserve Dual Gram-Negative Coverage For High Risk
- Use double gram-negative coverage only for high-risk settings until cultures return, then de-escalate quickly.
- Double coverage's goal is to avoid missing active therapy, not to speed microbial clearance.
De-Escalate By Clinical Trajectory When Cultures Are Negative
- When cultures are negative, base de-escalation on clear clinical improvement and readiness for extubation.
- If the patient isn't improving by 3–4 days, stop adding antibiotics and reassess the diagnosis.